Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
about
Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity.T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancerDiamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer TherapyTumor Microenvironment Targeted Nanotherapy
P2860
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
@en
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
@nl
type
label
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
@en
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
@nl
prefLabel
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
@en
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
@nl
P2093
P2860
P50
P356
P1476
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
@en
P2093
Anna M Giusti
Carsten Wolter
Dominik Rüttinger
Hadassah Sade
Michael A Cannarile
Yvonne Kienast
P2860
P304
P356
10.1084/JEM.20171440
P407
P50
P577
2018-02-07T00:00:00Z